Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page
- Check3 days agoChange DetectedThe page’s revision tag changed from v3.6.5 to v3.6.6, indicating deployment of a newer version of the page template.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing v3.6.4, indicating a new site release. This change represents a software update rather than a modification to study details or content.SummaryDifference0.0%

- Check38 days agoChange DetectedNew revision tag 'Revision: v3.6.4' appears, replacing 'Revision: v3.6.3' on the page. This indicates a minor site update rather than a change to the study information.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a recent site update that does not alter the study details presented.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing v3.6.0. This represents a software version update for the page's interface without changing trial details.SummaryDifference0.0%

- Check81 days agoChange DetectedThe study record now indicates that recruitment has ended and the sponsor terminated the study, with no participants being sought going forward.SummaryDifference0.4%

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.